Premium
Neonatal polycythaemia: critical review and a consensus statement of the Israeli Neonatology Association
Author(s) -
Mimouni Francis B,
Merlob Paul,
Dollberg Shaul,
Mandel Dror
Publication year - 2011
Publication title -
acta paediatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2011.02305.x
Subject(s) - medicine , polycythaemia , intensive care medicine , necrotizing enterocolitis , asymptomatic , pediatrics , neonatology , confounding , pregnancy , biology , genetics
The aim of this paper is to critically review neonatal polycythaemia (NP) literature, in terms of definition, diagnosis and management. We reviewed all Medline articles on NP up to December 2009. (i) The textbook definition of NP [venous haematocrit (HCT) > 65%] is empirical and not based on statistical definition, symptoms or complications. (ii) Measurement of viscosity is not better than HCT in predicting complications. (iii) Normovolaemic NP because of increased erythropoiesis may be different from hypervolaemic polycythaemia because of excessive foetal transfusion. (iv) Coexisting hypoglycaemia may worsen long‐term outcome. (v) Four clinical trials (CTs) studied partial exchange transfusion (PET) on outcomes. In all trials, PET was performed after 6 h of life. There is no evidence that PET improves neurodevelopmental outcome of asymptomatic NP, and it might increase the risk of necrotizing enterocolitis. These CTs have inherent design flaws: (a) CNS ‘damage’ may occur before PET. (b) Confounding variables that may affect outcome have not been studied. (vi) If PET is performed, normal saline is the best alternative. (vii) The long‐term effect of PET on symptomatic infants has not been studied. Conclusion: Current definition and management of NP are little evidence based, thus the need for a consensus based on expert opinion.